Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.

IMPORTANCE Randomized clinical trials suggest the benefit of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke is time dependent. However, modest sample sizes have limited characterization of the extent to which onset to treatment (OTT) time influences outcome; and the generalizability of findings to clinical practice is uncertain. OBJECTIVE To evaluate the degree to which OTT time is associated with outcome among patients with acute ischemic stroke treated with intraveneous tPA. DESIGN, SETTING, AND PATIENTS Data were analyzed from 58,353 patients with acute ischemic stroke treated with tPA within 4.5 hours of symptom onset in 1395 hospitals participating in the Get With The Guidelines-Stroke Program, April 2003 to March 2012. MAIN OUTCOMES AND MEASURES Relationship between OTT time and in-hospital mortality, symptomatic intracranial hemorrhage, ambulatory status at discharge, and discharge destination. RESULTS Among the 58,353 tPA-treated patients, median age was 72 years, 50.3% were women, median OTT time was 144 minutes (interquartile range, 115-170), 9.3% (5404) had OTT time of 0 to 90 minutes, 77.2% (45,029) had OTT time of 91 to 180 minutes, and 13.6% (7920) had OTT time of 181 to 270 minutes. Median pretreatment National Institutes of Health Stroke Scale documented in 87.7% of patients was 11 (interquartile range, 6-17). Patient factors most strongly associated with shorter OTT included greater stroke severity (odds ratio [OR], 2.8; 95% CI, 2.5-3.1 per 5-point increase), arrival by ambulance (OR, 5.9; 95% CI, 4.5-7.3), and arrival during regular hours (OR, 4.6; 95% CI, 3.8-5.4). Overall, there were 5142 (8.8%) in-hospital deaths, 2873 (4.9%) patients had intracranial hemorrhage, 19,491 (33.4%) patients achieved independent ambulation at hospital discharge, and 22,541 (38.6%) patients were discharged to home. Faster OTT, in 15-minute increments, was associated with reduced in-hospital mortality (OR, 0.96; 95% CI, 0.95-0.98; P < .001), reduced symptomatic intracranial hemorrhage (OR, 0.96; 95% CI, 0.95-0.98; P < .001), increased achievement of independent ambulation at discharge (OR, 1.04; 95% CI, 1.03-1.05; P < .001), and increased discharge to home (OR, 1.03; 95% CI, 1.02-1.04; P < .001). CONCLUSIONS AND RELEVANCE In a registry representing US clinical practice, earlier thrombolytic treatment was associated with reduced mortality and symptomatic intracranial hemorrhage, and higher rates of independent ambulation at discharge and discharge to home following acute ischemic stroke. These findings support intensive efforts to accelerate hospital presentation and thrombolytic treatment in patients with stroke.

[1]  J. Saver,et al.  Abstract TP379: The Relation Between Destination on Hospital Discharge and Final 3 Month Disability Outcome in Acute Ischemic Stroke , 2013, Stroke.

[2]  Atte Meretoja,et al.  Reducing in-hospital delay to 20 minutes in stroke thrombolysis , 2012, Neurology.

[3]  V. Haunton,et al.  The face arm speech test: does it encourage rapid recognition of important stroke warning symptoms? , 2012, Emergency Medicine Journal.

[4]  Eric E. Smith,et al.  Emergency Medical Service Hospital Prenotification Is Associated With Improved Evaluation and Treatment of Acute Ischemic Stroke , 2012, Circulation. Cardiovascular quality and outcomes.

[5]  Geoff Cohen,et al.  Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis , 2012, The Lancet.

[6]  Gary A. Ford,et al.  Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase: Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score , 2012, Stroke.

[7]  Eric E. Smith,et al.  Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit. , 2012, American heart journal.

[8]  Joseph P. Broderick,et al.  Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke , 2012, Journal of the American Heart Association.

[9]  Eric E. Smith,et al.  Representativeness of the Get With The Guidelines–Stroke Registry: Comparison of Patient and Hospital Characteristics Among Medicare Beneficiaries Hospitalized With Ischemic Stroke , 2012, Stroke.

[10]  Eric D. Peterson,et al.  Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic StrokeClinical Perspective , 2011 .

[11]  Lorenz Breuer,et al.  Avoiding in Hospital Delays and Eliminating the Three-Hour Effect in Thrombolysis for Stroke , 2011, International journal of stroke : official journal of the International Stroke Society.

[12]  Gregory W Albers,et al.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.

[13]  Jeffrey L. Saver,et al.  Alteplase for ischaemic stroke—much sooner is much better , 2010, The Lancet.

[14]  M. Paik,et al.  A stroke preparedness RCT in a multi-ethnic cohort: design and methods. , 2010, Contemporary clinical trials.

[15]  M. Kaste,et al.  Ultraearly Thrombolysis in Acute Ischemic Stroke Is Associated With Better Outcome and Lower Mortality , 2010, Stroke.

[16]  J. Saver,et al.  Day-90 Acute Ischemic Stroke Outcomes Can Be Derived from Early Functional Activity Level , 2009, Cerebrovascular Diseases.

[17]  J. Grotta,et al.  Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial , 2009, Stroke.

[18]  Maarten Schrooten,et al.  Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale , 2009, Stroke.

[19]  L. Thomassen,et al.  Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre , 2009, Emergency Medicine Journal.

[20]  Li Liang,et al.  Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2009, Circulation.

[21]  A. Rabinstein.  Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2009 .

[22]  L. Schwamm,et al.  Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program. , 2008, Archives of internal medicine.

[23]  J. Grotta,et al.  A Randomized, Controlled Trial to Teach Middle School Children to Recognize Stroke and Call 911: The Kids Identifying and Defeating Stroke Project , 2007, Stroke.

[24]  A. Pancioli,et al.  Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council. , 2007, Stroke.

[25]  P. Lindsay,et al.  Can Mass Media Influence Emergency Department Visits for Stroke? , 2007, Stroke.

[26]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[27]  W. Heiss,et al.  The Cologne Stroke Experience: Safety and Outcome in 450 Patients Treated with Intravenous Thrombolysis , 2007, Cerebrovascular Diseases.

[28]  J. Saver.  Time Is Brain—Quantified , 2006, Stroke.

[29]  V. Hachinski,et al.  Predictors of major neurologic improvement after thrombolysis in acute stroke , 2005, Neurology.

[30]  Peter Moyer,et al.  Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association’s Task Force on the Development of Stroke Systems , 2005, Circulation.

[31]  T. Duong,et al.  Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia , 2004, Annals of neurology.

[32]  A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. , 1997, Stroke.